Prise en charge d’une femme enceinte immunisée RH : 32,−46 : à propos d’un cas
Dominique Cottier, M Boénnec, Audrey Seigeot, Agnès Mailloux(Sorbonne Université), Vincent Thonier(Institut National de la Transfusion Sanguine), Marie Cuingnet(Institut National de la Transfusion Sanguine), A. Cortey(Sorbonne Université)
Cited by 0
Related Papers
Proteomic study of human umbilical vein endothelial cells in culture
|PROTEOMICS|2003|100
Anticancer drugs induce necrosis of human endothelial cells involving both oncosis and apoptosis
|European Journal of Cell Biology|2001|82
Proteomics of human umbilical vein endothelial cells applied to etoposide‐induced apoptosis
|PROTEOMICS|2005|70
Management of Very Early Fetal Anemia Resulting From Red-Cell Alloimmunization Before 20 Weeks of Gestation
|Obstetrics and Gynecology|2011|49
Determination of optimal timing of serial <i>in‐utero</i> transfusions in red‐cell alloimmunization
|Ultrasound in Obstetrics and Gynecology|2014|41